RW Investment Management LLC Has $647,000 Holdings in Agilent Technologies, Inc. (NYSE:A)

RW Investment Management LLC trimmed its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 2.8% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,988 shares of the medical research company’s stock after selling 144 shares during the period. RW Investment Management LLC’s holdings in Agilent Technologies were worth $647,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in A. Western Pacific Wealth Management LP grew its stake in shares of Agilent Technologies by 18.9% during the 1st quarter. Western Pacific Wealth Management LP now owns 440 shares of the medical research company’s stock worth $64,000 after acquiring an additional 70 shares in the last quarter. Ballentine Partners LLC grew its position in Agilent Technologies by 2.5% in the first quarter. Ballentine Partners LLC now owns 2,963 shares of the medical research company’s stock valued at $431,000 after purchasing an additional 73 shares in the last quarter. Haverford Trust Co grew its position in Agilent Technologies by 1.7% in the first quarter. Haverford Trust Co now owns 4,423 shares of the medical research company’s stock valued at $644,000 after purchasing an additional 74 shares in the last quarter. Menard Financial Group LLC increased its stake in Agilent Technologies by 1.6% in the 2nd quarter. Menard Financial Group LLC now owns 4,845 shares of the medical research company’s stock valued at $628,000 after buying an additional 77 shares during the last quarter. Finally, Salem Investment Counselors Inc. lifted its position in Agilent Technologies by 4.4% during the 1st quarter. Salem Investment Counselors Inc. now owns 2,259 shares of the medical research company’s stock worth $329,000 after buying an additional 95 shares in the last quarter. 87.42% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total value of $283,910.00. Following the transaction, the chief executive officer now owns 24,118 shares in the company, valued at $3,497,110. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.33% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on A. Stifel Nicolaus restated a “buy” rating and issued a $151.00 price objective on shares of Agilent Technologies in a report on Monday, August 26th. Robert W. Baird cut their price objective on Agilent Technologies from $147.00 to $136.00 and set an “outperform” rating for the company in a report on Thursday, May 30th. TD Cowen boosted their target price on shares of Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. Barclays increased their price target on shares of Agilent Technologies from $125.00 to $135.00 and gave the company an “underweight” rating in a research note on Friday, August 23rd. Finally, Jefferies Financial Group restated a “hold” rating and set a $135.00 price objective (down from $152.00) on shares of Agilent Technologies in a research note on Monday, June 3rd. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and nine have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $141.60.

Agilent Technologies Stock Performance

Shares of NYSE A opened at $140.09 on Friday. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. The firm has a market cap of $40.87 billion, a price-to-earnings ratio of 33.12, a P/E/G ratio of 6.43 and a beta of 1.05. The stock’s fifty day moving average price is $137.87 and its two-hundred day moving average price is $139.21. Agilent Technologies, Inc. has a one year low of $96.80 and a one year high of $155.35.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, topping analysts’ consensus estimates of $1.26 by $0.06. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.56 billion. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. Agilent Technologies’s revenue for the quarter was down 5.6% compared to the same quarter last year. During the same period last year, the firm earned $1.43 earnings per share. On average, equities analysts forecast that Agilent Technologies, Inc. will post 5.24 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st will be paid a $0.236 dividend. This represents a $0.94 annualized dividend and a dividend yield of 0.67%. The ex-dividend date of this dividend is Tuesday, October 1st. Agilent Technologies’s dividend payout ratio (DPR) is currently 22.22%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.